688553.SH
Sichuan Huiyu Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.04
+1.01%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 10.94
From 52W high−29.80%
Volume9.25M
Market capCNY 7.54B
P/E (TTM)−301.9x
P/S (TTM)6.8x
Div yield1.80%
Key dataSep 18, 2026
Open
CNY 10.94
From 52W high
−29.80%
Volume
9.25M
Market cap
CNY 7.54B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
210.2x
P/E (TTM)
−301.9x
RSI (14)
42.9
MomentumView details →
1D Return
+1.01%
YTD Return
—
Similar companies
Latest newsMore news →
Huiyu Pharmaceutical shareholder Huang Qianyi plans to passively reduce up to 2.46% of the company's shares (no more than 15.3923 million shares) via centralized bidding and block trades between October 19, 2026 and January 16, 2027 due to judicial enforcement.3d agoHuiyu Pharmaceutical said it will continue to expand the scope of AI tool applications based on actual R&D scenarios.6d agoHuiyu Pharmaceutical's wholly-owned subsidiary Huiyu Haiyue received approval from China's National Medical Products Administration to conduct clinical trials for its investigational drug HY07121 (subcutaneous injection) for treating advanced solid tumors.32d ago